Max Healthcare Approves ₹87.87 Crore Equity Infusion into Subsidiary Kalinga Hospital
Max Healthcare Institute Ltd · Others (Uncategorized) · 03 Sept 2026, 8:59 pm
Max Healthcare Approves ₹87.87 Crore Equity Infusion into Subsidiary Kalinga Hospital On 3rd Sep'26, Max Healthcare approved a ₹87.87 Crore cash infusion into its existing subsidiary, Kalinga Hospital Ltd. (KHL), via a rights issue subscription. Expected to close within 15 days, the capital will fund KHL’s capex, modernization initiatives, and capital structure optimization while strengthening clinical capabilities. KHL reported FY26 operating revenues of ~₹155.64 Crore and a paid-up capital of ₹21.54 Crore. The strategic transaction is exempt from SEBI's related-party restrictions and supports broader corporate requirements without altering the parent's primary line of business.
Original exchange filing (PDF)
More announcements from Max Healthcare Institute Ltd
- Presentation for Investor Conference · 14 Nov 2026
- Transcript of Earnings Call held on November 3, 2026 · 10 Nov 2026
- Schedule of Investor Conference · 05 Nov 2026
- Audio Recording of Earnings Call held on November 3, 2026 · 04 Nov 2026
- Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 04 Nov 2026
- Change in Senior Management Personnel · 30 Oct 2026
- Presentation of earnings update for the quarter and half year ended September 30, 2026 · 30 Oct 2026
- Press Release - Max Healthcare Q2 revenue rises to Rs. 3,219 Cr, registering growth of 20% YoY; Q2 PAT stood at Rs. 448 Cr, growth of 10% YoY · 30 Oct 2026
